0001415889-24-012149.txt : 20240503
0001415889-24-012149.hdr.sgml : 20240503
20240503161014
ACCESSION NUMBER: 0001415889-24-012149
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240501
FILED AS OF DATE: 20240503
DATE AS OF CHANGE: 20240503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Russo Rene
CENTRAL INDEX KEY: 0001722066
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 24913146
MAIL ADDRESS:
STREET 1: C/O ARSANIS, INC.
STREET 2: 890 WINTER STREET, SUITE 230
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-05032024_040501.xml
X0508
4
2024-05-01
0001840233
Xilio Therapeutics, Inc.
XLO
0001722066
Russo Rene
828 WINTER STREET
SUITE 300
WALTHAM
MA
02451
true
true
false
false
PRESIDENT AND CEO
0
Stock Option (right to buy)
1.08
2024-05-01
4
A
0
474000
0
A
2034-04-30
Common Stock
474000
474000
D
The option award was granted on May 1, 2024 and shall vest on June 1, 2024 with respect to 1/48th of the shares of common stock underlying the stock option and continue to vest in equal monthly installments thereafter until May 1, 2028.
/s/ Chris Frankenfield, Attorney-in-Fact
2024-05-03